secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2023-12-11T23:59:59+00:00
Accession:  0001213900-23-094779
Event type: debt
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phoenix Biotech Acquisition Corp. boosts sponsor note limit to $1.6M from $1.5M
-------------------------------------------------------------------------------

- First Amendment to Promissory Note raises maximum principal from $1.5M to $1.6M.
- Approximately $1.4M had been drawn under the note as of December 8, 2023.
- All other material terms unchanged; note matures upon consummation of initial business combination.
- Note is with sponsor Phoenix Biotech Sponsor, LLC; executed December 8, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390023094779/0001213900-23-094779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390023094779/ea189698-8k425_phoenix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-094779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer